佰金生命科学(01466)根据一般授权发行4000万股

Core Viewpoint - Baijin Life Sciences (01466) announced the issuance of 40 million new shares on November 28, 2025, based on the general authorization approved by shareholders on September 30, 2024 [1] Group 1 - The company will issue a total of 40 million new shares [1] - The issuance is contingent upon shareholder approval received on September 30, 2024 [1] - The scheduled date for the share issuance is November 28, 2025 [1]